skip to Main Content

Eyedaptic presents Clinical Trial for Augmented Reality Software to Restore Hope at CSUN Assistive Technology Conference

With millions of Americans impacted by diminishing vision and retinal disorders, ophthalmologists and low vision specialists are keen to find a restorative solution that allows freedom of movement and regained independence. To date, there has been little to offer this growing demographic as most current visual aid solutions offer little more than magnification which fails to address independence and inhibits mobility during use.

The California State University at Northridge (CSUN) 34th Assistive Technology Conference held at the Anaheim Marriott March 13, 2019, gathers together researchers, practitioners and speakers to share knowledge on the best practices in the field of assistive technologies. Known as the largest conference of its kind globally, this educational forum showcases innovative technologies and practical solutions designed to remove the barriers that prevent those with disabilities from leading full and productive lives, both at work and play.

In an educational session to be held on March 13 at 4:20pm, Dr. Mitul Mehta, MD., co-founder and Chief Medical Officer of Eyedaptic, will present important clinical trial data on a pivotal augmented reality (AR) visual aid offering life-changing impact to those struggling with age-related macular degeneration (AMD), low vision or other retinal conditions. Dr. Mehta is a Clinical Assistant Professor of Ophthalmology, specializing in medical and surgical diseases of the retina, at UCI’s Gavin Herbert Eye Institute.

The presentation will include key insights from the recent Eyedaptic EYE-01 efficacy data from its inaugural clinical trial along with usability data from extended in-home usage. The Eyedaptic story features insights from those with previously limited activity due to low vision who are now experiencing greater independence, increased quality of life and improved reading acuity.

“We are pleased to be presenting this important data at the CSUN Assistive Technology Conference,” stated Jay Cormier, Eyedaptic CEO and Co-Founder. “We are eager to share our mission and commitment to users with low vision and demonstrate how the use of our augmented reality software can restore independence and improve quality of life.”

“We are excited for this opportunity to share this useful data with the Low Vision Assistive Device Community,” added Dr. Mitul Mehta.  “We have seen first-hand how our proprietary technology from the first-generation prototype has already changed lives for the better.”

Eyedaptic is a privately-held visual aid software company, powered by augmented reality (AR) hardware, designed for AMD and other retinal disorders. The proprietary Simulated Natural Vision software goes beyond magnification to enable a fuller field of vision, key to those with central vision disorders.

Back To Top Skip to content